Under the direction of Dr. Emily Treleaven, the Michigan team will be responsible for: (1) managing the preparation of final data files; (2) supervising data management and related outputs, including final questionnaires and codebooks; (3) creating the trial profile; (4) beginning analysis of main effects of the intervention (under-five mortality) with Dr. Liu; (5) beginning secondary endpoint analyses related to newborn, infant, and child health; (6) supporting additional secondary analyses and manuscript preparation with other study investigators and team members.
Funding:
University of California, San Francisco (UCSF)
Funding Period:
07/01/2020 to 12/31/2024